CIK: 1337845 - Address: C/O Allovir, Inc., 1100 Winter Street, Waltham, MA 02451
21 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/21/24 16:33
5/17/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS-20.74930-3017,805D
5/7/24 16:15
5/3/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS-40.79600-5017,808D
4/23/24 16:15
4/19/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS.m-30.75030-3017,813D
4/4/24 16:15
4/2/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS-10.77200-1017,816D
2/22/24 16:15
2/20/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS-20.69520-3017,817D
2/6/24 16:46
2/5/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS-120.67000-18017,820D
1/25/24 16:15
1/23/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS-20.67080-3017,838D
1/8/24 16:15
1/4/24
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS-10.63900-1017,842D
11/21/23 17:00
11/17/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS-41.630-2017,843D
10/23/23 17:00
10/19/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS.m-41.560-3017,845D
10/5/23 17:00
10/3/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS-11.980-1017,848D
8/21/23 17:00
8/17/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS-262.500-11017,848D
7/21/23 17:00
7/19/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS.m-93.440-3017,859D
7/6/23 17:00
7/5/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS-93.050-3017,862D
4/21/23 16:05
4/19/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS.m-103.660-3017,860D
1/23/23 19:00
1/19/23
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS.m-335.090-7017,705D
10/26/22 16:15
10/20/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS.a-149.360-101,037D
10/24/22 18:28
10/19/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOTSee RemaS-149.360-1017,712D
7/21/22 19:12
7/20/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOSee RemaS-75.210-1014,359D
4/22/22 08:29
4/20/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOSee RemaS-86.680-1014,328D
1/24/22 16:15
1/20/22
ALVRAllovir, Inc.DEHealthBioPrdBiological Products, (No DiagSinha VikasMADOSee RemaS-568.750-6014,280D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact